LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

Bon Vivant joins EuropaBio: dairy products with a lower impact on human health, animals and planet

21/09/2022
PRESS RELEASE

Bon Vivant joins EuropaBio: dairy products with a lower impact on human health, animals and planet

Brussels, 21 September 2022 – EuropaBio is pleased to announce that Bon Vivant has joined as a corporate member.

Bon Vivant is a French biotech company developing, producing and transforming milk proteins using proprietary precision fermentation technology. The milk proteins produced by Bon Vivant are 100% identical to those produced by the cows but without lactose, without cholesterol, without antibiotics and with a much lower environmental impact.

EuropaBio Director-General Dr. Claire Skentelbery commented “We are excited to welcome another member working on sustainable dairy products through biotechnology. Together, we are the future of a more sustainable and competitive food industry in Europe”.

Bon Vivant Co-Founder and CEO, Stéphane Mac Millan, added: “We cannot wait to cooperate with EuropaBio to raise awareness on what we are doing, what is precision fermentation, why this is important that we as European we embrace these technologies, why when it comes to food we cannot continue to only rely on one source of production but we need to create a mix of food production, how the regulation should evolve, what are the potential drawback and how to avoid them”.

Bon Vivant joins EuropaBio


Download
2022_09_G_PR_Bon-Vivant-joins-EuropaBioDownload
Share
Alexandra Simionca
Alexandra Simionca

Related posts

03/07/2025

Life Sciences Strategy Embraces Biotech for Global Impact


Read more
26/06/2025

EuropaBio AGM 2025: Association Chair, Executive Committee and Board announced


Read more
25/06/2025

Hawkwood Biotech joins EuropaBio: Supporting Industrial Biotech with their Critical Challenges


Read more

Important links

  • EuropaBio Position on the Critical Medicines Act
  • Life Sciences Strategy Embraces Biotech for Global Impact

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.